Literature DB >> 3124997

Antibody-dependent cell-mediated cytotoxicity against human eye muscle cells and orbital fibroblasts in Graves' ophthalmopathy--roles of class II MHC antigen expression and gamma-interferon action of effector and target cells.

Y Hiromatsu1, H Fukazawa, J How, J R Wall.   

Abstract

We have studied the significance of antibody dependent cell-mediated cytotoxicity (ADCC) against human orbital fibroblasts (OF) and eye muscle (EM) cells in the pathogenesis of the orbital autoimmune reactions of Graves' ophthalmopathy (GO). Possible roles of Class II MHC antigen expression on the surface of orbital target cells and of gamma-interferon (gamma-IFN) modulation of ADCC were also studied. Both OF and EM expressed HLA-DR antigen when stimulated with gamma-IFN and phytohemagglutinin, but not spontaneously, and not by thyroid stimulating hormone or alpha-IFN. Intrathyroidal T cells from a patient with GO induced greater DR expression on both OF and EM cells than equal numbers of her peripheral blood T cells. gamma-IFN treated EM and OF were more susceptible to lysis in ADCC assays than untreated targets. gamma-IFN also enhanced lysis in ADCC assays by an effect on the killer cell population. On the other hand treatment with alpha-IFN, which is a potent inducer of Class I antigen expression, did not affect the susceptibility of target cells to lysis in ADCC. When sera from patients with GO were tested in ADCC, tests were positive (% specific lysis greater than mean + 2 s.d. for normals) in 10 of 20 patients with EM cells, but in only two of 25 with OF. The degree of killing of EM cells was significantly positively correlated to that of abdominal skeletal muscle cells and, to a lesser degree, normal thyroid cells, but not OF. In sera showing killing of EM cells and OF, ADCC activity against EM cells was absorbed by preincubation with EM and orbital connective tissue membranes but not thyroglobulin and, conversely, lysis of THY cells was absorbed by preincubation of positive sera on monolayers of THY and EM cells and OF, but not vascular endothelial (VE) cells. Finally, killing of 51Cr labelled EM cells was inhibited by addition of unlabelled ('cold') thyroid cells, EM cells and OF, but not VE cells. Our findings suggest that ADCC is likely to be an important mechanism for the eye muscle cell damage of GO, but not for the associated orbital connective tissue inflammation. Since ADCC is not MHC-restricted the enhanced lysis of HLA-DR positive target cells presumably reflects other effects of gamma-IFN treatment on both the killer cell population and the target cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3124997      PMCID: PMC1542178     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  22 in total

1.  Lectin-induced expression of DR antigen on human cultured follicular thyroid cells.

Authors:  R Pujol-Borrell; T Hanafusa; L Chiovato; G F Bottazzo
Journal:  Nature       Date:  1983 Jul 7-13       Impact factor: 49.962

2.  Ophthalmopathy of Graves' disease.

Authors:  C Gorman
Journal:  N Engl J Med       Date:  1983-02-24       Impact factor: 91.245

3.  Graft-versus-host disease induces expression of Ia antigen in rat epidermal cells and gut epithelium.

Authors:  D W Mason; M Dallman; A N Barclay
Journal:  Nature       Date:  1981 Sep 10-16       Impact factor: 49.962

4.  Interferon-induced resistance of fibroblasts to cytolysis mediated by natural killer cells: specificity and mechanism.

Authors:  G Trinchieri; D Granato; B Perussia
Journal:  J Immunol       Date:  1981-01       Impact factor: 5.422

5.  Clinical significance of a new autoantibody against a human eye muscle soluble antigen, detected by immunofluorescence.

Authors:  M Mengistu; E Laryea; A Miller; J R Wall
Journal:  Clin Exp Immunol       Date:  1986-07       Impact factor: 4.330

6.  Cell-mediated immunity in the exophthalmos of Graves' disease as demonstrated by the migration inhibition factor (MIF) test.

Authors:  R E Munro; L Lamki; V V Row; R Volpé
Journal:  J Clin Endocrinol Metab       Date:  1973-08       Impact factor: 5.958

7.  Recombinant immune interferon increases immunoglobulin G Fc receptors on cultured human mononuclear phagocytes.

Authors:  P M Guyre; P M Morganelli; R Miller
Journal:  J Clin Invest       Date:  1983-07       Impact factor: 14.808

8.  Aberrant expression of HLA-DR antigen on thyrocytes in Graves' disease: relevance for autoimmunity.

Authors:  T Hanafusa; R Pujol-Borrell; L Chiovato; R C Russell; D Doniach; G F Bottazzo
Journal:  Lancet       Date:  1983-11-12       Impact factor: 79.321

9.  Demonstration of a circulating autoantibody against a soluble eye-muscle antigen in Graves' ophthalmopathy.

Authors:  K Kodama; H Sikorska; P Bandy-Dafoe; R Bayly; J R Wall
Journal:  Lancet       Date:  1982-12-18       Impact factor: 79.321

10.  Isolation and characterization of mononuclear cells from various thyroid tissue specimens.

Authors:  R J Baur; J R Wall; H Schleusener
Journal:  Life Sci       Date:  1983 Jan 3-10       Impact factor: 5.037

View more
  9 in total

1.  Histopathologic analysis of palpebral conjunctiva in thyroid-related orbitopathy (an american ophthalmological society thesis).

Authors:  Don O Kikkawa
Journal:  Trans Am Ophthalmol Soc       Date:  2010-12

Review 2.  Autoimmunity in Graves' ophthalmopathy: a review.

Authors:  A P Weetman
Journal:  J R Soc Med       Date:  1989-03       Impact factor: 5.344

3.  Extraocular muscle changes in experimental orbital venous stasis: some similarities to Graves' orbitopathy.

Authors:  E Saber; J McDonnell; K M Zimmermann; J E Yugar; S E Feldon
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-05       Impact factor: 3.117

4.  Immunohistochemical analysis of the retrobulbar tissues in Graves' ophthalmopathy.

Authors:  A P Weetman; S Cohen; K C Gatter; P Fells; B Shine
Journal:  Clin Exp Immunol       Date:  1989-02       Impact factor: 4.330

5.  Antibodies against striated muscle, connective tissue and nuclear antigens in patients with thyroid-associated ophthalmopathy: should Graves' disease be considered a collagen disorder?

Authors:  J I Kiljanski; K Peele; I Stachura; J Pickeral; C Stolarski; J S Kennerdell; J R Wall
Journal:  J Endocrinol Invest       Date:  1997-11       Impact factor: 4.256

Review 6.  Graves' ophthalmopathy: what is the evidence for extraocular muscle specific autoantibodies.

Authors:  R van der Gaag; R Vernimmen; N Fiebelkorn; M C van Dierendonck; A Kijlstra
Journal:  Int Ophthalmol       Date:  1990-01       Impact factor: 2.031

7.  Antibody-dependent cell-mediated cytotoxicity against orbital target cells in thyroid-associated ophthalmopathy and related disorders; close relationship between serum cytotoxic antibodies and parameters of eye muscle dysfunction.

Authors:  A Barsouk; K A Peele; J Kiljanski; C Stolarski; V Nebes; J S Kennerdell; R Volpe; J R Wall
Journal:  J Endocrinol Invest       Date:  1996-06       Impact factor: 4.256

Review 8.  Potential Roles of CD34+ Fibrocytes Masquerading as Orbital Fibroblasts in Thyroid-Associated Ophthalmopathy.

Authors:  Terry J Smith
Journal:  J Clin Endocrinol Metab       Date:  2019-02-01       Impact factor: 5.958

9.  Failure to demonstrate cell-mediated immunity to orbital tissue antigens and epitopic fragments of a 64 kDa protein in the majority of patients with thyroid-associated ophthalmopathy.

Authors:  J Kiljanski; C Stolarski; A Barsouk; V Nebes; J R Wall
Journal:  J Endocrinol Invest       Date:  1996-05       Impact factor: 4.256

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.